Navigation Links
Higher Education Foundation in Brazil Seals Its Continued Relationship with Thomson Reuters for Academic Healthcare Content
Date:11/9/2010

BRASILIA, Brazil, Nov. 9, 2010 /PRNewswire/ -- The Coordination for the Improvement of Personnel in Higher Education (CAPES) today hosts an official signing ceremony, celebrating the 10th anniversary of Portal de Periodicos. CAPES will sign contract renewals with Thomson Reuters and other international publishers who are part of the Portal.

Thomson Reuters is pleased to provide CAPES with access to its Micromedex® solutions, which include evidence-based information on drugs and drug interactions, disease management, toxicology, alternative medicine, and intravenous drug compatibility. By tapping into this integrated reference source, CAPES ensures that Brazil's students are kept up-to-date with the world's best clinical evidence.

It is important for CAPES to provide Brazil's scholarly community access to the world's leading publishers. Medical and pharmacy students, clinical researchers and other members of national academic programs, through Thomson Reuters, can tap into the world's best clinical evidence on drugs and disease.

Affiliated to the Ministry of Education, CAPES is responsible for the Brazilian post graduate academic system. It works as an agency to support, evaluate, regulate and set rules that guide academic programs with the aim of achieving standards of excellence.

The Portal de Periodicos was created in November 2000 to deliver online access to current scientific content in order to reduce regional differences in the Brazilian research and post graduate system.  It provides more than 268 institutions with access to more than 15,000 journals.

About CAPES

CAPES is a Foundation within the Ministry of Education in Brazil whose central purpose is to coordinate efforts to improve the quality of Brazil's faculty and staff in higher education through grant programs. CAPES is particularly concerned with the training of Doctoral candidates, Pre-doctoral short-term researchers, and Post-doctoral Scholars.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization.  With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries.  For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ
2. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
3. Obesity-Related Hormone is Higher in Children with Down Syndrome
4. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
5. Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
6. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
7. Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
10. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
11. Study Finds Family History, Higher Incidence of Sunburns Associated With Rosacea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/18/2017)... Pa. and KALAMAZOO, Mich. , Sept. 18, ... , and OptiMed Specialty Pharmacy of ... to offer a strategic hub service that expedites and ... sought-after personal spirometer, Spiro PD 2.0, and wellness management ... spirometer is a medical device used to measure lung ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... ... How many things are on your average daily to-do list? If your ... human could possibly complete,” then you’re all too familiar with daily chaos. You have ... everything to everybody all the time. , Self-proclaimed overly productive person Angela Nuttle knows ...
(Date:9/25/2017)... ... September 25, 2017 , ... NCPDP Foundation , ... it has awarded a $40,000 grant to Johns Hopkins Medicine to address patient ... enables prescribers to electronically cancel a prescription already submitted to a pharmacy. Studies ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... nationally syndicated The Sharon Kleyne Hour Power of Water, Global Climate Change and ... shift our Olympic focus from a once-every-four-years series of events to a personal, ...
(Date:9/25/2017)... ... September 25, 2017 , ... Bobbie Horowitz was hardly able to ... health issues. As a cabaret and theater producer, Horowitz would manage to get to ... transportation in New York City, so she had to take a cab everywhere. ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... and technology-enabled services supporting clinical research, today announces that 30 of its ... of the drug development lifecycle at upcoming industry conferences and webinars. Drawing ...
Breaking Medicine News(10 mins):